We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$192M
2
CB icon
Chubb
CB
+$160M
3
AMD icon
Advanced Micro Devices
AMD
+$144M
4
DIS icon
Walt Disney
DIS
+$134M
5
CVS icon
CVS Health
CVS
+$132M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRXP icon
3826
NRX Pharmaceuticals
NRXP
$155M
$43 ﹤0.01%
+17
New +$57
PRQR icon
3827
ProQR Therapeutics
PRQR
$244M
$43 ﹤0.01%
+33
New +$52
SABS icon
3828
SAB Biotherapeutics
SABS
$263M
$43 ﹤0.01%
+7
New +$51
UBX
3829
DELISTED
Unity Biotechnology
UBX
$43 ﹤0.01%
+18
New +$48
IH
3830
iHuman
IH
$68.5M
$42 ﹤0.01%
+14
New +$43
CCVI
3831
DELISTED
Churchill Capital Corp VI
CCVI
$42 ﹤0.01%
+4
New +$42
DNTH icon
3832
Dianthus Therapeutics
DNTH
$5.71B
$41 ﹤0.01%
+3
New +$38
ATOS icon
3833
Atossa Therapeutics
ATOS
$23.5M
$40 ﹤0.01%
+4
New +$58
CMMB
3834
Chemomab Therapeutics
CMMB
$10.4M
$39 ﹤0.01%
+11
New +$51
SEGG
3835
Sports Entertainment Gaming Global Corp
SEGG
$14.4M
$39 ﹤0.01%
+1
New +$41
QCLS
3836
Q/C Technologies Inc
QCLS
$25.3M
– –
0
– –
ASMB icon
3837
Assembly Biosciences
ASMB
$513M
$38 ﹤0.01%
+4
New +$48
BGSF icon
3838
BGSF Inc
BGSF
$55.7M
$38 ﹤0.01%
+4
New +$39
CZWI icon
3839
Citizens Community Bancorp
CZWI
$206M
$38 ﹤0.01%
+4
New +$40
VVOS icon
3840
Vivos Therapeutics
VVOS
$5.6M
$38 ﹤0.01%
+8
New +$60
CNTB
3841
Connect Biopharma Holdings
CNTB
$132M
$36 ﹤0.01%
+46
New +$42
WWR icon
3842
Westwater Resources
WWR
$50.8M
$35 ﹤0.01%
+52
New +$40
ASXC
3843
DELISTED
Asensus Surgical, Inc.
ASXC
$35 ﹤0.01%
+129
New +$47
DMTK
3844
DELISTED
DermTech, Inc. Common Stock
DMTK
$35 ﹤0.01%
+24
New +$60
CLGN icon
3845
CollPlant Biotechnologies
CLGN
$6.03M
$34 ﹤0.01%
+6
New +$40
ZKIN icon
3846
ZK International Group
ZKIN
$69.9M
$34 ﹤0.01%
+7
New +$30
VIP
3847
Vulcan Infrastructure and Power Inc. Class A Common Stock
VIP
$40.6M
$33 ﹤0.01%
+8
New +$43
GSUN icon
3848
Golden Sun Technology Group
GSUN
$2.01M
$33 ﹤0.01%
+4
New +$35
TBHC
3849
DELISTED
The Brand House Collective
TBHC
$33 ﹤0.01%
+19
New +$50
GPUS
3850
Hyperscale Data Inc
GPUS
$56.4M
– –
0
– –
152 153
154
155 156

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.